CEACAM1 and neoplasm: Recent advances in the genetic manipulation of F. nucleatum134, 160 have facilitated the ability to weaken fusobacterial tumor‐enhancing actions in the future by for example mutating FadA and/or nullifying TIGIT and CEACAM1 activation.